Opioid use persisted for months after head and neck radiotherapy, even in the opioid-naive

Design

Single-institution retrospective cohort

Population

789 patients with non-metastatic head and neck cancer treated with radiation or chemoradiation

Primary outcome

Opioid use 3 months after radiation

Effect

70.0% at 3 months and 47.3% at 6 months; 57.8% and 37.8% in opioid-naive patients

This single-institution US cohort followed 789 patients with non-metastatic head and neck cancer treated with definitive radiation or chemoradiation between 2011 and 2023, for a median of 47 months. It was published in October.

Between diagnosis and six months after radiation, 95% received prescription opioids. At three months after radiation, 70% were still taking them, and at six months 47%. Among the 296 who were opioid-naive before radiation, 58% and 38% were still using opioids at three and six months. Continued use at three months was associated with prior opioid use (adjusted OR 2.57), former smoking (1.55) and palliative care referral (3.90). Underweight opioid-naive patients started opioids sooner.

Mucositis pain during radiotherapy is severe and opioids are often appropriate. The concern is what happens afterwards, when acute pain settles but prescriptions continue without a plan. These data support planning the exit at the start: setting expectations, agreeing review points and tapering as mucositis heals. Some continued use will reflect real ongoing pain, and the study could not separate that from dependence.

• Agree an opioid plan, including expected duration and review dates, before radiotherapy begins.
• Review every patient's opioid need at the end of treatment and again at 6 to 8 weeks.
• Taper opioids as mucositis heals rather than continuing the treatment-phase dose.
• Use non-opioid measures alongside: topical anaesthetics, mouth care and regular paracetamol where suitable.
• Take particular care with patients already on opioids, smokers and those with low weight.

Why it matters

Opioids started for treatment pain often outlast the pain, and there is rarely a named point at which someone stops them.

Don't overread it

This single-centre cohort cannot distinguish ongoing pain needing treatment from avoidable long-term use.

The statistics, in plain English

The 70% and 47% figures are proportions, not effects of a treatment, so there is no comparison group. The odds ratios identify who is more likely to keep taking opioids, but as associations they do not show that these factors cause continued use.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.